U.S. allows emergency use of Eli Lilly's Covid antibody therapy

The FDA said its emergency use authorization (EUA) was based on clinical trials showing that the treatment, bamlanivimab, reduced the need for hospitalization or emergency room visits in Covid-19 patients at high risk of disease progression.

from Top News and Analysis (pro) https://ift.tt/36AcTJF